knowledge landing page image

Full Federal Court clarifies limits on the ability of an exclusive licensee to sue for infringement of a patent

Extension of deadlines to submit modern slavery statements – What you need to know

For businesses who are required to submit their first modern slavery statement in Australia this year, there has been an extension of time to submit these statements by...

01 May 2020

Modern slavery risks during COVID-19 – what you need to know

This article is written by Daisy Mallett and Daniel FieldingThe Australian Border Force has released guidance on how businesses can reduce the risk of vulnerable workers in their...

24 April 2020

Australia’s first modern slavery statements are due this year: are you ready?

If your business is caught by the Modern Slavery Act 2018 (Cth) (the Act), you may have your first modern slavery statement due this year.

24 January 2020

Global moves to reduce the future cost of publicly funded medicines

In order to minimise pressure on health spending, regulators around the world are increasingly looking to promote the availability of ‘biosimilars’ - biological products that are highly similar...

05 October 2018
Categories: 

All eyes on payroll tax as optometrists win appeal in Commissioner of State Revenue v The Optical Superstore Pty Ltd [2018] VSC 524

On 21 September 2018, the Victorian Supreme Court dismissed an appeal by the Commissioner of State Revenue (Commissioner) in Commissioner of State Revenue v The Optical Superstore Pty...

28 September 2018

IP Australia releases proposed changes to Australia’s patent legislation

IP Australia has released an exposure draft for the proposed Intellectual Property Laws Amendment Bill which proposes several key changes to Australia’s patent laws

31 July 2018
Categories: 

Critical infrastructure: are you ready to report?

Starting on 11 July 2018, owners and operators of Australia’s critical infrastructure assets have 6 months to report current ownership and operating details.

11 July 2018

The final word and ‘smoking gun’ documents - ACCC v Pfizer

Federal Court of Australia dismisses ACCC appeal, finding Pfizer had not misused its substantial market power for an anti-competitive purpose, and had not engaged in exclusive dealing conduct....

05 June 2018

Biotech Insights: 2018 industry snapshot and key trends

Healthcare, medical technology and pharmaceutical innovation continue to be major areas of investment from a broad spectrum of local and off-shore funding bodies.

01 June 2018
Categories: 

Fast drugs, new drugs: new opportunities in the healthcare industry in Australia and China

Chinese and Australian businesses looking for overseas opportunities to expand in the healthcare industry should be aware of important regulatory changes.

27 April 2018

Australian Open Banking Review Released

It provides advice on the design and implementation of Australia’s Open Banking system and is the first stage in a broader consumer data right.

09 February 2018
Categories: 

Biosimilars: balancing access to affordable medicines with safety

The Australian regulatory position appears to reflect a stronger push towards the timely uptake of biosimilar medicines.

01 November 2017

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.